Search

everythinglearnresearchcommunity

for

Search:↓

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

The guide explains how to identify and treat children's hair loss, including fungal infections, autoimmune disorders, hairstyle changes, self-correcting conditions, and behavioral therapy for hair-pulling.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Different lab conditions and light treatment methods change how human skin cells respond to light therapy.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Iron deficiency is not a significant cause of hair loss in women.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

Many women with PCOS have undiagnosed health issues and show different symptoms based on the clinic they visit.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Intense exercise at night can delay the body's internal clock gene expression by 2 to 4 hours.

Low vitamin D receptor levels found in hair loss patients; topical vitamin D treatment suggested.

Ultraviolet rays damage hair, smoking may cause hair loss, and good nutrition is important for hair health, but genetics mainly decide hair thickness.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

Patients with myotonic dystrophy often have skin problems that suggest early aging and vitamin D issues, and the severity of these problems is linked to their genetic condition and vitamin D levels.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

Testosterone replacement therapy should be used for men with low testosterone levels and symptoms of hypogonadism, after careful diagnosis and considering individual needs.

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Finasteride reduces melanin production, possibly treating hyperpigmentation and melanoma, but needs more safety research.

A small number of premenopausal female blood donors had high prolactin levels, often due to stress, and retesting is recommended to prevent misdiagnosis.

PDGF-BB helps young melanocytes grow but stops mature ones from growing, and it makes melanocytes more specialized.

Alopecia areata patients have lower zinc, copper, and selenium levels than healthy people.

Pili anulati may cause hair loss, proper diagnosis and treatment needed.

Mild thyroid issues don't affect the metabolism and hormones of women with PCOS.

Most HIV patients develop skin symptoms that can indicate the stage of their disease.

LC-MS/MS is more reliable than immunoassays for diagnosing 21-hydroxylase deficiency.

The document concludes that early diagnosis and treatment are crucial for managing skin diseases in ferrets.